Mitsui and NVIDIA Announce Japan’s First Generative AI Supercomputer for Pharmaceutical Industry

Mitsui & Co., Ltd., one of Japan’s largest business conglomerates, is collaborating with NVIDIA on Tokyo-1 — an initiative to supercharge the nation’s pharmaceutical leaders with technology, including high-resolution molecular dynamics simulations and generative AI models for drug discovery. Announced today at the NVIDIA GTC global AI conference, the Tokyo-1 project features an NVIDIA DGX Read article >